The Discovery and Development of Liraglutide and Semaglutide

The discovery of glucagon-like peptide-1 (GLP-1), an incretin hormone with important effects on glycemic control and body weight regulation, led to efforts to extend its half-life and make it therapeutically effective in people with type 2 diabetes (T2D). The development of short- and then long-acti...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in endocrinology (Lausanne) Vol. 10; p. 155
Main Authors Knudsen, Lotte Bjerre, Lau, Jesper
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 12.04.2019
Subjects
Online AccessGet full text

Cover

Loading…